YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

BNIGF
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

globenewswire.comPOSITIVO

Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

NEW YORK and SYDNEY, June 01, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that it has received notification from its European Authorized Representati…

finance.yahoo.comPOSITIVO

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

Beroni Group Limited NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research,…

globenewswire.comPOSITIVO

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovat…

globenewswire.comPOSITIVO

Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

NEW YORK and SYDNEY, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovat…

globenewswire.comPOSITIVO

Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China

NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…

globenewswire.comPOSITIVO

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

NEW YORK and SYDNEY, Australia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…

globenewswire.comPOSITIVO

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced that its article entitled “Crystal struct…

finance.yahoo.comPOSITIVO

Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO

NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti…

finance.yahoo.comPOSITIVO

Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based…

globenewswire.comPOSITIVO

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the noti…

globenewswire.comPOSITIVO

Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company

NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces that it has completed its majority acquisition…

globenewswire.comPOSITIVO

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and comm…

globenewswire.comPOSITIVO

Beroni Group Launches a New Probiotics Health Product in China

NEW YORK and SYDNEY, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…

globenewswire.comPOSITIVO

Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise announced today that the Company has been reco…

finance.yahoo.comPOSITIVO

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…

globenewswire.comPOSITIVO

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…

finance.yahoo.comPOSITIVO

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…

globenewswire.comPOSITIVO

Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan

NEW YORK and SYDNEY, Australia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…

globenewswire.comPOSITIVO

Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

NEW YORK and SYDNEY, Australia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), is pleased to announce that further to its announcement on August 4, 2020 regarding the development of a m…

globenewswire.comPOSITIVO

Beroni Group Has Successfully Constructed and Purified 24 Types of Nanobodies for Detection and Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group to Supply COVID-19 Antibody Test Kit to Japan

NEW YORK and SYDNEY, Australia, July 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Dr Richard Buchta Appointed as Director of Beroni Group

NEW YORK and SYDNEY, Australia, June 30, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans

NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group R&D Team Identifies 24 Types of Nanobodies for Rapid Detection and Treatment of Coronavirus (COVID-19)

- Granted Approval by China Ministry of Commerce to Export Detection Kits Globally - - Obtained CE Certification by European Union - NEW YORK and SYDNEY, Australia, May 08, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“B…

globenewswire.comPOSITIVO

Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit Received CE Certification

NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…

globenewswire.comPOSITIVO

Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19

NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…

globenewswire.comPOSITIVO

Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit

NEW YORK and SYDNEY, Australia, March 26, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…

globenewswire.comPOSITIVO

Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)

- Cytological Experiments Commenced in March 2020 - - Clinical Trials to Commence in April 2020 - NEW YORK and SYDNEY, Australia, March 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an inte…

globenewswire.comPOSITIVO

Beroni Group Featured in New Research Initiation Report

NEW YORK and SYDNEY, Australia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA

NEW YORK and SYDNEY, Australia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group to Present at Biotech Showcase™ 2020 in San Francisco, USA

NEW YORK and SYDNEY, Australia, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…

globenewswire.comPOSITIVO

Beroni Group to Hold the Third Precision Medicine & Medical Care and Aging International Forum (with Conference Theme “Innovation Driving Development, Technology Leading Future”) in Tianjin, China on December 7-8, 2019

NEW YORK and SYDNEY, Australia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG; OTCQX: BNIGF) is pleased to announce that it will be holding the Third Precision Medicine & Medical Care and Aging International Forum (“Foru…

globenewswire.comPOSITIVO

Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses

NEW YORK and SYDNEY, Australia, Oct. 24, 2019 (GLOBE NEWSWIRE) -- In April 2019, Beroni Group Limited (“Beroni” or the “Company”) (NSX: BTG; OTCQX: BNIGF) signed an exclusive license agreement with Columbia University whereby Columbia Univ…

globenewswire.comPOSITIVO

Beroni USA is Ready to Commercialise a Diagnostic Kit for Detecting Zika, Dengue, Chikungunya and West Nile Viruses Worldwide

NEW YORK and SYDNEY, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (“Beroni’ or the “Company”) entered into an agreement with the Columbia University, New York (“Columbia University”) in March 2018 to provide US$1 mill…

globenewswire.comPOSITIVO

Beroni Group Launches its First-Ever Japan-Made Stem Cell Based Regenerative Skincare Products in the Rapidly Growing Chinese Consumer Market

NEW YORK and SYDNEY, Australia, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG) (OTCQX: BNIGF) (“Company”) is pleased to announce that after five months of filing the registration, it has now secured the approval of Chin…

globenewswire.comPOSITIVO

Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China

PLACEHOLDER, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG)(OTCQX: BNIGF) (“Beroni” or the “Company”) and Zhengzhou Jinshui Science & Education Park (“Jinshui Park”) have signed a strategic cooperation agreement to join…